Why Xeris Biopharma Holdings (XERS) Is Up 7.9% After Raising 2025 Revenue Outlook and Adding Patents
Patents, Intellectual Property News
Alongside the revenue upgrade, the company bolstered its intellectual property position with new U.S. patents for Recorlev and pipeline candidate XP- ...
